Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Melatonin for Prevention of Delirium in Critically Ill Patients: a Multi-centre, Randomized, Placebo-controlled Study.

NCT02615340 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.

NCT NCT02615340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Melatonin for Prevention of Delirium in Critically Ill Patients: a Multi-centre, Randomized, Placebo-controlled Study.
Lead sponsor
Mount Sinai Hospital, Canada
Phase
Phase 2
Overall status
Unknown status
Start date
October 12, 2017
Completion date
October 12, 2019
Enrollment
69 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

delirium